VEGFA and non-small cell lung carcinoma: Mechanistically, in NSCLC, VEGF activates several pathways, including PI3K/Akt, extracellular signal-regulated kinase 1/2 (ERK 1/2) and STAT3, which lead to increasing amounts of VEGF through an autocrine loop [36].